table of content
1 Introduction to Research & Analysis Reports
1.1 Human Vaccines Administered Orally Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Vaccines Administered Orally Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Vaccines Administered Orally Overall Market Size
2.1 Global Human Vaccines Administered Orally Market Size: 2022 VS 2030
2.2 Global Human Vaccines Administered Orally Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Human Vaccines Administered Orally Sales: 2018-2030
3 Company Landscape
3.1 Top Human Vaccines Administered Orally Players in Global Market
3.2 Top Global Human Vaccines Administered Orally Companies Ranked by Revenue
3.3 Global Human Vaccines Administered Orally Revenue by Companies
3.4 Global Human Vaccines Administered Orally Sales by Companies
3.5 Global Human Vaccines Administered Orally Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Human Vaccines Administered Orally Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Human Vaccines Administered Orally Product Type
3.8 Tier 1, Tier 2 and Tier 3 Human Vaccines Administered Orally Players in Global Market
3.8.1 List of Global Tier 1 Human Vaccines Administered Orally Companies
3.8.2 List of Global Tier 2 and Tier 3 Human Vaccines Administered Orally Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Human Vaccines Administered Orally Market Size Markets, 2022 & 2030
4.1.2 Rotavirus Vaccine
4.1.3 Cholera Vaccine
4.1.4 Oral Polio Vaccine
4.2 By Type - Global Human Vaccines Administered Orally Revenue & Forecasts
4.2.1 By Type - Global Human Vaccines Administered Orally Revenue, 2018-2023
4.2.2 By Type - Global Human Vaccines Administered Orally Revenue, 2024-2030
4.2.3 By Type - Global Human Vaccines Administered Orally Revenue Market Share, 2018-2030
4.3 By Type - Global Human Vaccines Administered Orally Sales & Forecasts
4.3.1 By Type - Global Human Vaccines Administered Orally Sales, 2018-2023
4.3.2 By Type - Global Human Vaccines Administered Orally Sales, 2024-2030
4.3.3 By Type - Global Human Vaccines Administered Orally Sales Market Share, 2018-2030
4.4 By Type - Global Human Vaccines Administered Orally Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Human Vaccines Administered Orally Market Size, 2022 & 2030
5.1.2 Public
5.1.3 Private
5.2 By Application - Global Human Vaccines Administered Orally Revenue & Forecasts
5.2.1 By Application - Global Human Vaccines Administered Orally Revenue, 2018-2023
5.2.2 By Application - Global Human Vaccines Administered Orally Revenue, 2024-2030
5.2.3 By Application - Global Human Vaccines Administered Orally Revenue Market Share, 2018-2030
5.3 By Application - Global Human Vaccines Administered Orally Sales & Forecasts
5.3.1 By Application - Global Human Vaccines Administered Orally Sales, 2018-2023
5.3.2 By Application - Global Human Vaccines Administered Orally Sales, 2024-2030
5.3.3 By Application - Global Human Vaccines Administered Orally Sales Market Share, 2018-2030
5.4 By Application - Global Human Vaccines Administered Orally Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Human Vaccines Administered Orally Market Size, 2022 & 2030
6.2 By Region - Global Human Vaccines Administered Orally Revenue & Forecasts
6.2.1 By Region - Global Human Vaccines Administered Orally Revenue, 2018-2023
6.2.2 By Region - Global Human Vaccines Administered Orally Revenue, 2024-2030
6.2.3 By Region - Global Human Vaccines Administered Orally Revenue Market Share, 2018-2030
6.3 By Region - Global Human Vaccines Administered Orally Sales & Forecasts
6.3.1 By Region - Global Human Vaccines Administered Orally Sales, 2018-2023
6.3.2 By Region - Global Human Vaccines Administered Orally Sales, 2024-2030
6.3.3 By Region - Global Human Vaccines Administered Orally Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Human Vaccines Administered Orally Revenue, 2018-2030
6.4.2 By Country - North America Human Vaccines Administered Orally Sales, 2018-2030
6.4.3 US Human Vaccines Administered Orally Market Size, 2018-2030
6.4.4 Canada Human Vaccines Administered Orally Market Size, 2018-2030
6.4.5 Mexico Human Vaccines Administered Orally Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Human Vaccines Administered Orally Revenue, 2018-2030
6.5.2 By Country - Europe Human Vaccines Administered Orally Sales, 2018-2030
6.5.3 Germany Human Vaccines Administered Orally Market Size, 2018-2030
6.5.4 France Human Vaccines Administered Orally Market Size, 2018-2030
6.5.5 U.K. Human Vaccines Administered Orally Market Size, 2018-2030
6.5.6 Italy Human Vaccines Administered Orally Market Size, 2018-2030
6.5.7 Russia Human Vaccines Administered Orally Market Size, 2018-2030
6.5.8 Nordic Countries Human Vaccines Administered Orally Market Size, 2018-2030
6.5.9 Benelux Human Vaccines Administered Orally Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Human Vaccines Administered Orally Revenue, 2018-2030
6.6.2 By Region - Asia Human Vaccines Administered Orally Sales, 2018-2030
6.6.3 China Human Vaccines Administered Orally Market Size, 2018-2030
6.6.4 Japan Human Vaccines Administered Orally Market Size, 2018-2030
6.6.5 South Korea Human Vaccines Administered Orally Market Size, 2018-2030
6.6.6 Southeast Asia Human Vaccines Administered Orally Market Size, 2018-2030
6.6.7 India Human Vaccines Administered Orally Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Human Vaccines Administered Orally Revenue, 2018-2030
6.7.2 By Country - South America Human Vaccines Administered Orally Sales, 2018-2030
6.7.3 Brazil Human Vaccines Administered Orally Market Size, 2018-2030
6.7.4 Argentina Human Vaccines Administered Orally Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Human Vaccines Administered Orally Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Human Vaccines Administered Orally Sales, 2018-2030
6.8.3 Turkey Human Vaccines Administered Orally Market Size, 2018-2030
6.8.4 Israel Human Vaccines Administered Orally Market Size, 2018-2030
6.8.5 Saudi Arabia Human Vaccines Administered Orally Market Size, 2018-2030
6.8.6 UAE Human Vaccines Administered Orally Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Human Vaccines Administered Orally Major Product Offerings
7.1.4 Merck Human Vaccines Administered Orally Sales and Revenue in Global (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 GSK
7.2.1 GSK Company Summary
7.2.2 GSK Business Overview
7.2.3 GSK Human Vaccines Administered Orally Major Product Offerings
7.2.4 GSK Human Vaccines Administered Orally Sales and Revenue in Global (2018-2023)
7.2.5 GSK Key News & Latest Developments
7.3 Sanofi
7.3.1 Sanofi Company Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Human Vaccines Administered Orally Major Product Offerings
7.3.4 Sanofi Human Vaccines Administered Orally Sales and Revenue in Global (2018-2023)
7.3.5 Sanofi Key News & Latest Developments
7.4 Lanzhou Institute
7.4.1 Lanzhou Institute Company Summary
7.4.2 Lanzhou Institute Business Overview
7.4.3 Lanzhou Institute Human Vaccines Administered Orally Major Product Offerings
7.4.4 Lanzhou Institute Human Vaccines Administered Orally Sales and Revenue in Global (2018-2023)
7.4.5 Lanzhou Institute Key News & Latest Developments
7.5 Serum Institute
7.5.1 Serum Institute Company Summary
7.5.2 Serum Institute Business Overview
7.5.3 Serum Institute Human Vaccines Administered Orally Major Product Offerings
7.5.4 Serum Institute Human Vaccines Administered Orally Sales and Revenue in Global (2018-2023)
7.5.5 Serum Institute Key News & Latest Developments
7.6 Valneva
7.6.1 Valneva Company Summary
7.6.2 Valneva Business Overview
7.6.3 Valneva Human Vaccines Administered Orally Major Product Offerings
7.6.4 Valneva Human Vaccines Administered Orally Sales and Revenue in Global (2018-2023)
7.6.5 Valneva Key News & Latest Developments
7.7 Shanghai United Cell
7.7.1 Shanghai United Cell Company Summary
7.7.2 Shanghai United Cell Business Overview
7.7.3 Shanghai United Cell Human Vaccines Administered Orally Major Product Offerings
7.7.4 Shanghai United Cell Human Vaccines Administered Orally Sales and Revenue in Global (2018-2023)
7.7.5 Shanghai United Cell Key News & Latest Developments
7.8 Bibcol
7.8.1 Bibcol Company Summary
7.8.2 Bibcol Business Overview
7.8.3 Bibcol Human Vaccines Administered Orally Major Product Offerings
7.8.4 Bibcol Human Vaccines Administered Orally Sales and Revenue in Global (2018-2023)
7.8.5 Bibcol Key News & Latest Developments
7.9 PaxVax
7.9.1 PaxVax Company Summary
7.9.2 PaxVax Business Overview
7.9.3 PaxVax Human Vaccines Administered Orally Major Product Offerings
7.9.4 PaxVax Human Vaccines Administered Orally Sales and Revenue in Global (2018-2023)
7.9.5 PaxVax Key News & Latest Developments
7.10 Vabiotech
7.10.1 Vabiotech Company Summary
7.10.2 Vabiotech Business Overview
7.10.3 Vabiotech Human Vaccines Administered Orally Major Product Offerings
7.10.4 Vabiotech Human Vaccines Administered Orally Sales and Revenue in Global (2018-2023)
7.10.5 Vabiotech Key News & Latest Developments
7.11 Tiantan Biological
7.11.1 Tiantan Biological Company Summary
7.11.2 Tiantan Biological Human Vaccines Administered Orally Business Overview
7.11.3 Tiantan Biological Human Vaccines Administered Orally Major Product Offerings
7.11.4 Tiantan Biological Human Vaccines Administered Orally Sales and Revenue in Global (2018-2023)
7.11.5 Tiantan Biological Key News & Latest Developments
7.12 EuBiologics
7.12.1 EuBiologics Company Summary
7.12.2 EuBiologics Human Vaccines Administered Orally Business Overview
7.12.3 EuBiologics Human Vaccines Administered Orally Major Product Offerings
7.12.4 EuBiologics Human Vaccines Administered Orally Sales and Revenue in Global (2018-2023)
7.12.5 EuBiologics Key News & Latest Developments
7.13 Panacea Biotec Ltd
7.13.1 Panacea Biotec Ltd Company Summary
7.13.2 Panacea Biotec Ltd Human Vaccines Administered Orally Business Overview
7.13.3 Panacea Biotec Ltd Human Vaccines Administered Orally Major Product Offerings
7.13.4 Panacea Biotec Ltd Human Vaccines Administered Orally Sales and Revenue in Global (2018-2023)
7.13.5 Panacea Biotec Ltd Key News & Latest Developments
7.14 Bio-Med
7.14.1 Bio-Med Company Summary
7.14.2 Bio-Med Business Overview
7.14.3 Bio-Med Human Vaccines Administered Orally Major Product Offerings
7.14.4 Bio-Med Human Vaccines Administered Orally Sales and Revenue in Global (2018-2023)
7.14.5 Bio-Med Key News & Latest Developments
7.15 Halfkin Bio-Pharmaceuticals
7.15.1 Halfkin Bio-Pharmaceuticals Company Summary
7.15.2 Halfkin Bio-Pharmaceuticals Business Overview
7.15.3 Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Major Product Offerings
7.15.4 Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Sales and Revenue in Global (2018-2023)
7.15.5 Halfkin Bio-Pharmaceuticals Key News & Latest Developments
8 Global Human Vaccines Administered Orally Production Capacity, Analysis
8.1 Global Human Vaccines Administered Orally Production Capacity, 2018-2030
8.2 Human Vaccines Administered Orally Production Capacity of Key Manufacturers in Global Market
8.3 Global Human Vaccines Administered Orally Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Human Vaccines Administered Orally Supply Chain Analysis
10.1 Human Vaccines Administered Orally Industry Value Chain
10.2 Human Vaccines Administered Orally Upstream Market
10.3 Human Vaccines Administered Orally Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Human Vaccines Administered Orally Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
